Jerry J. Buccafusco - Publications

Affiliations: 
Medical College of Georgia, Augusta, GA, United States 
Area:
Neuroscience Biology, Molecular Biology, Cell Biology

119 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Webster SJ, Mruthinti S, Hill WD, Buccafusco JJ, Terry AV. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Neuromolecular Medicine. 14: 119-30. PMID 22415896 DOI: 10.1007/s12017-012-8176-z  1
2012 Terry AV, Buccafusco JJ, Schade RF, Vandenhuerk L, Callahan PM, Beck WD, Hutchings EJ, Chapman JM, Li P, Bartlett MG. The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats. Biochemical Pharmacology. 83: 941-51. PMID 22244928 DOI: 10.1016/j.bcp.2011.12.043  0.8
2011 Zhou X, Qi XL, Douglas K, Palaninathan K, Kang HS, Buccafusco JJ, Blake DT, Constantinidis C. Cholinergic modulation of working memory activity in primate prefrontal cortex. Journal of Neurophysiology. 106: 2180-8. PMID 21795623 DOI: 10.1152/jn.00148.2011  0.8
2011 Hall BJ, Pearson LS, Terry AV, Buccafusco JJ. The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking. Neuropharmacology. 61: 798-806. PMID 21651919 DOI: 10.1016/j.neuropharm.2011.05.026  0.8
2011 Webster SJ, Wilson CA, Lee CH, Mohler EG, Terry AV, Buccafusco JJ. The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. British Journal of Pharmacology. 164: 970-8. PMID 21486290 DOI: 10.1111/j.1476-5381.2011.01432.x  0.8
2011 Terry AV, Buccafusco JJ, Gearhart DA, Beck WD, Middlemore-Risher ML, Truan JN, Schwarz GM, Xu M, Bartlett MG, Kutiyanawala A, Pillai A. Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function. Neuroscience. 176: 237-53. PMID 21185910 DOI: 10.1016/j.neuroscience.2010.12.031  0.8
2011 Terry AV, Buccafusco JJ, Herman EJ, Callahan PM, Beck WD, Warner S, Vandenhuerk L, Bouchard K, Schwarz GM, Gao J, Chapman JM. The prototypical ranitidine analog JWS-USC-75-IX improves information processing and cognitive function in animal models. The Journal of Pharmacology and Experimental Therapeutics. 336: 751-66. PMID 21106907 DOI: 10.1124/jpet.110.175422  0.8
2011 Kohlhaas KL, Robb H, Roderwald V, Markosyan S, Salte K, Bitner RS, Mohler E, Terry AV, Buccafusco J, Rueter LE, Lee L, Gopalakrishnan M. α7 NNR allosteric modulation in behavioral models of cognition Biochemical Pharmacology. 82: 1042. DOI: 10.1016/j.bcp.2011.07.050  1
2010 Millan MJ, Buccafusco JJ, Loiseau F, Watson DJ, Decamp E, Fone KC, Thomasson-Perret N, Hill M, Mocaer E, Schneider JS. The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1035-51. PMID 20663270 DOI: 10.1017/S1461145710000775  0.8
2010 Mitchell MB, Buccafusco JJ, Schade RF, Webster SJ, Mruthinti S, Harrell DU, Gulati NK, Miller LS. RAGE and Abeta immunoglobulins: relation to Alzheimer's disease-related cognitive function. Journal of the International Neuropsychological Society : Jins. 16: 672-8. PMID 20441687 DOI: 10.1017/S1355617710000469  0.8
2010 Middlemore-Risher ML, Buccafusco JJ, Terry AV. Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats. Neurotoxicology and Teratology. 32: 415-24. PMID 20350597 DOI: 10.1016/j.ntt.2010.03.008  1
2010 Hall BJ, Pearson LS, Buccafusco JJ. Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats. Neuroscience Letters. 474: 84-7. PMID 20226229 DOI: 10.1016/j.neulet.2010.03.011  0.8
2010 Buccafusco JJ, Terry AV, Vazdarjanova A, Snutch TP, Arneric SP. Treatments for neuropathic pain differentially affect delayed matching accuracy by macaques: effects of amitriptyline and gabapentin. Pain. 148: 446-53. PMID 20092945 DOI: 10.1016/j.pain.2009.12.003  0.8
2010 Hall BJ, Pearson LS, Buccafusco JJ. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal. Neuropharmacology. 58: 429-35. PMID 19772864 DOI: 10.1016/j.neuropharm.2009.09.009  0.8
2010 LIN N, GUNN DE, RYTHER KB, GARVEY DS, DONNELLY-ROBERTS DL, DECKER MW, BRIONI JD, BUCKLEY MJ, RODRIGUES AD, MARSH KG, ANDERSON DJ, BUCCAFUSCO JJ, PRENDERGAST MA, SULLIVAN JP, WILLIAMS M, et al. ChemInform Abstract: Structure-Activity Studies on 2-Methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties. Cheminform. 28: no-no. DOI: 10.1002/chin.199719153  0.64
2009 Buccafusco JJ, Terry AV. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Biochemical Pharmacology. 78: 852-62. PMID 19577545 DOI: 10.1016/j.bcp.2009.06.102  1
2009 Wilson JS, Mruthinti S, Buccafusco JJ, Schade RF, Mitchell MB, Harrell DU, Gulati NK, Miller LS. Anti-RAGE and Abeta immunoglobulin levels are related to dementia level and cognitive performance. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 64: 264-71. PMID 19196906 DOI: 10.1093/gerona/gln002  0.8
2009 Buccafusco JJ, Beach JW, Terry AV. Desensitization of nicotinic acetylcholine receptors as a strategy for drug development. The Journal of Pharmacology and Experimental Therapeutics. 328: 364-70. PMID 19023041 DOI: 10.1124/jpet.108.145292  1
2009 Buccafusco JJ, Webster SJ, Terry AV, Kille N, Blessing D. Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task. Psychopharmacology. 202: 477-85. PMID 18784917 DOI: 10.1007/s00213-008-1318-1  1
2009 Rueter LE, Browman KE, Buccafusco JJ, Buckley MJ, Decker MW. P4-337: The scopolamine-induced deficit model is a viable translational approach that can expedite decision making in clinical development: Preclinical evidence Alzheimer's & Dementia. 5: e29-e29. DOI: 10.1016/j.jalz.2009.07.116  0.52
2008 Terry AV, Buccafusco JJ, Wilson C. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets. Behavioural Brain Research. 195: 30-8. PMID 18241938 DOI: 10.1016/j.bbr.2007.12.006  1
2008 Buccafusco JJ, Terry AV, Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology. 199: 481-94. PMID 17657478 DOI: 10.1007/s00213-007-0887-8  0.8
2008 Buccafusco JJ, Terry AV, Webster SJ. O4-04-01: Prolonged cognitive enhancement exhibited by monkeys after single doses of clonidine Alzheimer's & Dementia. 4: T190-T191. DOI: 10.1016/j.jalz.2008.05.527  1
2007 Mruthinti S, Capito N, Sood A, Buccafusc JJ. Cytotoxicity of Abeta1-42, RAGE23-54, and an Abeta-RAGE complex in PC-12 cells. Current Alzheimer Research. 4: 581-6. PMID 18220528 DOI: 10.2174/156720507783018325  0.56
2007 Buccafusco JJ, Bain JN. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline. Neuroscience. 149: 487-98. PMID 17916413 DOI: 10.1016/j.neuroscience.2007.07.027  0.4
2007 Buccafusco JJ, Terry AV, Decker MW, Gopalakrishnan M. Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. Biochemical Pharmacology. 74: 1202-11. PMID 17706609 DOI: 10.1016/j.bcp.2007.07.010  1
2007 Sood A, Warren Beach J, Webster SJ, Terry AV, Buccafusco JJ. The effects of JWB1-84-1 on memory-related task performance by amyloid Abeta transgenic mice and by young and aged monkeys. Neuropharmacology. 53: 588-600. PMID 17698153 DOI: 10.1016/j.neuropharm.2007.06.028  1
2007 Terry AV, Gearhart DA, Beck WD, Truan JN, Middlemore ML, Williamson LN, Bartlett MG, Prendergast MA, Sickles DW, Buccafusco JJ. Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing. The Journal of Pharmacology and Experimental Therapeutics. 322: 1117-28. PMID 17548533 DOI: 10.1124/jpet.107.125625  1
2007 Buccafusco JJ, Powers JC, Hernandez MA, Prendergast MA, Terry AV, Jonnala RR. MHP-133, a drug with multiple CNS targets: potential for neuroprotection and enhanced cognition. Neurochemical Research. 32: 1224-37. PMID 17404838 DOI: 10.1007/s11064-007-9489-4  1
2007 Buccafusco JJ, Shuster LC, Terry AV. Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine. Neuroscience Letters. 413: 68-71. PMID 17157984 DOI: 10.1016/j.neulet.2006.11.028  1
2007 Gearhart DA, Sickles DW, Buccafusco JJ, Prendergast MA, Terry AV. Chlorpyrifos, chlorpyrifos-oxon, and diisopropylfluorophosphate inhibit kinesin-dependent microtubule motility. Toxicology and Applied Pharmacology. 218: 20-9. PMID 17123561 DOI: 10.1016/j.taap.2006.10.008  1
2007 Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 190: 269-319. PMID 16896961 DOI: 10.1007/s00213-006-0441-0  0.8
2006 Mruthinti S, Sood A, Humphrey CL, Swamy-Mruthinti S, Buccafusco JJ. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products. Neuroscience. 142: 463-73. PMID 16890367 DOI: 10.1016/j.neuroscience.2006.06.010  0.6
2006 Mruthinti S, Schade RF, Harrell DU, Gulati NK, Swamy-Mruthinti S, Lee GP, Buccafusco JJ. Autoimmunity in Alzheimer's disease as evidenced by plasma immunoreactivity against RAGE and Abeta42: complication of diabetes. Current Alzheimer Research. 3: 229-35. PMID 16842100 DOI: 10.2174/156720506777632899  0.8
2006 Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. British Journal of Pharmacology. 148: 565-78. PMID 16751797 DOI: 10.1038/sj.bjp.0706780  0.8
2006 De Luca CJ, Buccafusco JJ, Roy SH, De Luca G, Nawab SH. The electromyographic signal as a presymptomatic indicator of organophosphates in the body. Muscle & Nerve. 33: 369-76. PMID 16307441 DOI: 10.1002/mus.20466  0.8
2005 Terry AV, Hernandez CM, Hohnadel EJ, Bouchard KP, Buccafusco JJ. Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition. Cns Drug Reviews. 11: 229-52. PMID 16389292 DOI: 10.1111/j.1527-3458.2005.tb00045.x  0.8
2005 Li XD, Arias E, Jonnala RR, Mruthinti S, Buccafusco JJ. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo. Journal of Molecular Neuroscience : Mn. 27: 325-36. PMID 16280603 DOI: 10.1385/JMN:27:3:325  1
2005 Graham JH, Papke RL, Buccafusco JJ. Functional central nicotinic acetylcholine receptor antagonism by systemic administration of Tinuvin 770 (BTMPS). Current Alzheimer Research. 2: 141-7. PMID 15974911 DOI: 10.2174/1567205053585747  0.8
2005 Terry AV, Buccafusco JJ, Bartoszyk GD. Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys. Psychopharmacology. 179: 725-32. PMID 15619109 DOI: 10.1007/s00213-004-2114-1  1
2005 Buccafusco JJ, Davis JA, Shuster LC, Buccafusco CJ, Gattu M. The importance of brainstem cholinergic neurons in the pressor response to cocaine. The Journal of Pharmacology and Experimental Therapeutics. 312: 179-91. PMID 15328378 DOI: 10.1124/jpet.104.073619  0.72
2004 Buccafusco JJ, Beach JW, Terry AV, Doad GS, Sood A, Arias E, Misawa H, Masai M, Fujii T, Kawashima K. Novel analogs of choline as potential neuroprotective agents. Journal of Alzheimer's Disease : Jad. 6: S85-92. PMID 15665419 DOI: 10.3233/JAD-2004-6S612  1
2004 Buccafusco JJ, Terry AV. Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys. Journal of Molecular Neuroscience : Mn. 24: 85-91. PMID 15314255 DOI: 10.1385/JMN:24:1:085  1
2004 Mruthinti S, Buccafusco JJ, Hill WD, Waller JL, Jackson TW, Zamrini EY, Schade RF. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiology of Aging. 25: 1023-32. PMID 15212827 DOI: 10.1016/j.neurobiolaging.2003.11.001  0.8
2004 Li XD, Buccafusco JJ. Role of alpha7 nicotinic acetylcholine receptors in the pressor response to intracerebroventricular injection of choline: blockade by amyloid peptide Abeta1-42. The Journal of Pharmacology and Experimental Therapeutics. 309: 1206-12. PMID 14976229 DOI: 10.1124/jpet.103.063321  0.8
2004 Buccafusco JJ, Weiser T, Winter K, Klinder K, Terry AV. The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys. Neuropharmacology. 46: 10-22. PMID 14654093 DOI: 10.1016/j.neuropharm.2003.07.002  1
2003 Elkins RL, Orr TE, Rausch JL, Fei YJ, Carl GF, Hobbs SH, Buccafusco JJ, Edwards GL. Cocaine-induced expression differences in PSD-95/SAP-90-associated protein 4 and in Ca2+/calmodulin-dependent protein kinase subunits in amygdalae of taste aversion-prone and taste aversion-resistant rats. Annals of the New York Academy of Sciences. 1003: 386-90. PMID 14684468 DOI: 10.1196/annals.1300.068  0.8
2003 Elkins RL, Orr TE, Rausch JL, Fei YJ, Carl GF, Hobbs SH, Buccafusco JJ, Edwards GL. Cocaine-induced expression differences in glutamate receptor subunits and transporters in amygdalae of taste aversion-prone and taste aversion-resistant rats. Annals of the New York Academy of Sciences. 1003: 381-5. PMID 14684467 DOI: 10.1196/annals.1300.067  0.8
2003 Mruthinti S, Hill WD, Swamy-Mruthinti S, Buccafusco JJ. Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites. Journal of Molecular Neuroscience : Mn. 20: 223-32. PMID 14501001 DOI: 10.1385/JMN:20:3:223  0.52
2003 Li XD, Buccafusco JJ. Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells. The Journal of Pharmacology and Experimental Therapeutics. 307: 670-5. PMID 12970390 DOI: 10.1124/jpet.103.053785  0.8
2003 Buccafusco JJ, Terry AV, Goren T, Blaugrun E. Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task. Neuroscience. 119: 669-78. PMID 12809688 DOI: 10.1016/S0306-4522(02)00937-5  1
2003 Terry AV, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. The Journal of Pharmacology and Experimental Therapeutics. 306: 821-7. PMID 12805474 DOI: 10.1124/jpet.102.041616  1
2003 Bain JN, Prendergast MA, Terry AV, Arneric SP, Smith MA, Buccafusco JJ. Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. Psychopharmacology. 169: 150-60. PMID 12768267 DOI: 10.1007/s00213-003-1483-1  1
2003 Buccafusco JJ, Terry AV. The potential role of cotinine in the cognitive and neuroprotective actions of nicotine. Life Sciences. 72: 2931-42. PMID 12706481 DOI: 10.1016/S0024-3205(03)00226-1  1
2003 Terry AV, Stone JD, Buccafusco JJ, Sickles DW, Sood A, Prendergast MA. Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning. The Journal of Pharmacology and Experimental Therapeutics. 305: 375-84. PMID 12649392 DOI: 10.1124/jpet.102.041897  0.8
2003 Buccafusco JJ, Jackson WJ, Stone JD, Terry AV. Sex dimorphisms in the cognitive-enhancing action of the Alzheimer's drug donepezil in aged Rhesus monkeys. Neuropharmacology. 44: 381-9. PMID 12604096 DOI: 10.1016/S0028-3908(02)00378-7  0.8
2003 Jonnala RR, Graham JH, Terry AV, Beach JW, Young JA, Buccafusco JJ. Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors. Synapse (New York, N.Y.). 47: 262-9. PMID 12539199 DOI: 10.1002/syn.10176  0.8
2002 Buccafusco JJ, Terry AV, Murdoch PB. A computer-assisted cognitive test battery for aged monkeys. Journal of Molecular Neuroscience : Mn. 19: 179-85. PMID 12212778 DOI: 10.1007/s12031-002-0030-6  1
2002 Terry AV, Buccafusco JJ, Borsini F, Leusch A. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine. Psychopharmacology. 162: 292-300. PMID 12122487 DOI: 10.1007/s00213-002-1105-3  1
2002 Terry AV, Risbrough VB, Buccafusco JJ, Menzaghi F. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys. The Journal of Pharmacology and Experimental Therapeutics. 301: 284-92. PMID 11907185 DOI: 10.1124/jpet.301.1.284  1
2002 Jonnala RR, Terry AV, Buccafusco JJ. Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. Life Sciences. 70: 1543-54. PMID 11895105 DOI: 10.1016/S0024-3205(01)01529-6  1
2001 Jonnala RR, Buccafusco JJ. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. Journal of Neuroscience Research. 66: 565-72. PMID 11746376 DOI: 10.1002/jnr.10022  1
2001 Terry AV, Hernandez CM, Buccafusco JJ. Dahl salt-sensitive and salt-resistant rats: Examination of learning and memory performance, blood pressure, and the expression of central nicotinic acetylcholine receptors Neuroscience. 103: 351-363. PMID 11246150 DOI: 10.1016/S0306-4522(00)00569-8  0.8
2001 Jonnala RR, Buccafusco JJ. Inhibition of nerve growth factor signaling by peroxynitrite. Journal of Neuroscience Research. 63: 27-34. PMID 11169611 DOI: 10.1002/1097-4547(20010101)63:1<27::AID-JNR4>3.0.CO;2-#  1
2000 Terry AV, Hernandez CM, Buccafusco JJ, Gattu M. Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats Neuroscience. 101: 357-368. PMID 11074159 DOI: 10.1016/S0306-4522(00)00377-8  0.8
2000 Stone JD, Terry AV, Pauly JR, Prendergast MA, Buccafusco JJ. Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. Brain Research. 882: 9-18. PMID 11056179 DOI: 10.1016/S0006-8993(00)02689-5  0.8
2000 Evans-Martin FF, Terry AV, Jackson WJ, Buccafusco JJ. Evaluation of two rodent delayed-response memory tasks: a method with retractable levers versus a method with closing doors. Physiology & Behavior. 70: 233-41. PMID 11006421 DOI: 10.1016/S0031-9384(00)00233-X  1
2000 Zhang LC, Buccafusco JJ. Adaptive changes in M1 muscarinic receptors localized to specific rostral brain regions during and after morphine withdrawal. Neuropharmacology. 39: 1720-31. PMID 10884554 DOI: 10.1016/S0028-3908(00)00012-5  0.4
2000 Buccafusco JJ, Zhang LC, Shuster LC, Jonnala RR, Gattu M. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Brain Research. 852: 76-83. PMID 10661498 DOI: 10.1016/S0006-8993(99)02197-6  1
1999 Buccafusco JJ, Jackson WJ, Jonnala RR, Terry AV. Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys. Behavioural Pharmacology. 10: 681-90. PMID 10780510 DOI: 10.1097/00008877-199911000-00015  1
1999 Zhang LC, Buccafusco JJ. Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms. Brain Research. 803: 114-21. PMID 9729319 DOI: 10.1016/S0006-8993(98)00635-0  0.4
1999 Terry A, Gattu M, Buccafusco J, Sowell J, Kosh J. Ranitidine analog, JWS-USC-75IX, enhances memory-related task performance in rats Drug Development Research. 47: 97-106. DOI: 10.1002/(SICI)1098-2299(199906)47:2<97::AID-DDR5>3.0.CO;2-I  0.72
1998 Paule MG, Bushnell PJ, Maurissen JP, Wenger GR, Buccafusco JJ, Chelonis JJ, Elliott R. Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicology and Teratology. 20: 493-502. PMID 9761587 DOI: 10.1016/S0892-0362(98)00013-0  0.8
1998 Prendergast MA, Buccafusco JJ. (-)-Nicotine increases mRNA encoding G3PDH and the vesicular acetylcholine transporter in vivo Neuroreport. 9: 1385-1389. PMID 9631434 DOI: 10.1097/00001756-199805110-00025  0.8
1998 Prendergast MA, Jackson WJ, Terry AV, Kille NJ, Arneric SP, Decker MW, Buccafusco JJ. Age-related differences in distractibility and response to methylphenidate in monkeys. Cerebral Cortex (New York, N.Y. : 1991). 8: 164-72. PMID 9542895 DOI: 10.1093/cercor/8.2.164  1
1998 Terry AV, Buccafusco JJ, Jackson WJ, Prendergast MA, Fontana DJ, Wong EH, Bonhaus DW, Weller P, Eglen RM. Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017. Psychopharmacology. 135: 407-15. PMID 9539266 DOI: 10.1007/s002130050529  1
1998 Prendergast MA, Jackson WJ, Terry AV, Decker MW, Arneric SP, Buccafusco JJ. Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys. Psychopharmacology. 136: 50-8. PMID 9537682 DOI: 10.1007/s002130050538  1
1998 Prendergast MA, Terry AV, Buccafusco JJ. Effects of chronic, low-level organophosphate exposure on delayed recall, discrimination, and spatial learning in monkeys and rats. Neurotoxicology and Teratology. 20: 115-22. PMID 9536457 DOI: 10.1016/S0892-0362(97)00098-6  1
1997 Gattu M, Pauly JR, Urbanawiz S, Buccafusco JJ. Autoradiographic comparison of muscarinic M1 and M2 binding sites in the CNS of spontaneously hypertensive and normotensive rats. Brain Research. 771: 173-83. PMID 9401737 DOI: 10.1016/S0006-8993(97)00691-4  0.8
1997 Gattu M, Terry AV, Pauly JR, Buccafusco JJ. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II. Brain Research. 771: 104-14. PMID 9383013 DOI: 10.1016/S0006-8993(97)00794-4  0.8
1997 Gattu M, Pauly JR, Boss KL, Summers JB, Buccafusco JJ. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I. Brain Research. 771: 89-103. PMID 9383012 DOI: 10.1016/S0006-8993(97)00793-2  0.8
1997 Gattu M, Boss KL, Terry AV, Buccafusco JJ. Reversal of scopolamine-induced deficits in navigational memory performance by the seed oil of Celastrus paniculatus. Pharmacology, Biochemistry, and Behavior. 57: 793-9. PMID 9259008 DOI: 10.1016/S0091-3057(96)00391-7  1
1997 Buccafusco JJ, Shuster LC. Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms. Brain Research Bulletin. 43: 321-6. PMID 9227843 DOI: 10.1016/S0361-9230(97)00013-0  0.68
1997 Gattu M, Wei J, Pauly JR, Urbanawiz S, Buccafusco JJ. Increased expression of M2 muscarinic receptor mRNA and binding sites in the rostral ventrolateral medulla of spontaneously hypertensive rats. Brain Research. 756: 125-32. PMID 9187322 DOI: 10.1016/S0006-8993(97)00126-1  0.8
1997 Prendergast MA, Buccafusco JJ, Terry AV. Nitric oxide synthase inhibition impairs spatial navigation learning and induces conditioned taste aversion. Pharmacology, Biochemistry, and Behavior. 57: 347-52. PMID 9164593 DOI: 10.1016/S0091-3057(96)00313-9  1
1997 Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, Campbell JE, Decker MW, Donnelly-Roberts D, Elliott RL, Gopalakrishnan M, Holladay MW, Hui YH, Jackson WJ, Kim DJ, Marsh KC, et al. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacology, Biochemistry, and Behavior. 57: 231-41. PMID 9164577 DOI: 10.1016/S0091-3057(96)00354-1  0.8
1997 Prendergast MA, Terry AV, Jackson WJ, Marsh KC, Decker MW, Arneric SP, Buccafusco JJ. Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418. Psychopharmacology. 130: 276-84. PMID 9151363 DOI: 10.1007/s002130050240  1
1997 Terry AV, Buccafusco JJ, Prendergast MA, Jackson WJ, Fontana DL, Wong EH, Whiting RL, Eglen RM. The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys. Neuroreport. 8: 49-54. PMID 9051751 DOI: 10.1097/00001756-199612200-00011  1
1997 Prendergast MA, Terry AV, Buccafusco JJ. Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning. Psychopharmacology. 129: 183-91. PMID 9040125 DOI: 10.1007/s002130050179  1
1997 Lin NH, Gunn DE, Ryther KB, Garvey DS, Donnelly-Roberts DL, Decker MW, Brioni JD, Buckley MJ, Rodrigues AD, Marsh KG, Anderson DJ, Buccafusco JJ, Prendergast MA, Sullivan JP, Williams M, et al. Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties. Journal of Medicinal Chemistry. 40: 385-90. PMID 9022806 DOI: 10.1021/jm960233u  0.64
1997 Prendergast MA, Terry AV, Jackson WJ, Buccafusco JJ. Nitric oxide synthase inhibition impairs delayed recall in mature monkeys. Pharmacology, Biochemistry, and Behavior. 56: 81-7. PMID 8981613 DOI: 10.1016/S0091-3057(96)00160-8  1
1997 Starks KM, Ortega-Vilain AC, Buccafusco JJ, Powers JC. Novel pyridinium derivatives as inhibitors for acetylcholinesterase. Journal of Enzyme Inhibition. 10: 27-45. PMID 8835928 DOI: 10.3109/14756369509021469  0.64
1997 Buccafusco JJ, Powers JC. Stimulation of Brain Nicotinic Acetylcholine Receptors (nAChR) and Inhibition of Brain Acetylcholinesterase (AChE) Activity Emerging Therapeutic Targets. 1: 85-88. DOI: 10.1517/14728222.1.1.85  0.64
1997 Terry AV, Buccafusco J, Decker M. Cholinergic channel activator, ABT-418, enhances delayed-response accuracy in rats Drug Development Research. 40: 304-312. DOI: 10.1002/(SICI)1098-2299(199704)40:4<304::AID-DDR4>3.0.CO;2-N  1
1996 Feldman DS, Terry AV, Buccafusco JJ. Spinal muscarinic cholinergic and nitric oxide systems in cardiovascular regulation European Journal of Pharmacology. 313: 211-220. PMID 8911917 DOI: 10.1016/0014-2999(96)00513-4  0.8
1996 Terry AV, Buccafusco JJ, Jackson WJ, Zagrodnik S, Evans-Martin FF, Decker MW. Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task. Psychopharmacology. 123: 172-81. PMID 8741940 DOI: 10.1007/BF02246174  1
1996 Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology. 120: 256-66. PMID 8524972 DOI: 10.1007/BF02311172  1
1995 Gattu M, Terry AV, Buccafusco JJ. A rapid microtechnique for the estimation of muscarinic and nicotinic receptor binding parameters using 96-well filtration plates. Journal of Neuroscience Methods. 63: 121-25. PMID 8788056 DOI: 10.1016/0165-0270(95)00100-X  1
1995 Buccafusco JJ, Jackson WJ, Gattu M, Terry AV. Isoarecolone-induced enhancement of delayed matching to sample performance in monkeys: role of nicotinic receptors. Neuroreport. 6: 1223-7. PMID 7662913 DOI: 10.1097/00001756-199505300-00037  1
1995 Buccafusco JJ, Terry AV, Shuster L. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat. Brain Research. 679: 189-99. PMID 7633880 DOI: 10.1016/0006-8993(95)00203-3  1
1995 Jackson WJ, Buccafusco JJ, Terry AV, Turk DJ, Rush DK. Velnacrine maleate improves delayed matching performance by aged monkeys. Psychopharmacology. 119: 391-8. PMID 7480518 DOI: 10.1007/BF02245854  0.8
1995 Arneric SP, Anderson DJ, Bannon AW, Briggs CA, Buccafusco JJ, Brioni JD, Cannon JB, Decker MW, Donnelly-Roberts D, Gopalakrishnan M, Holladay MW, Kyncl J, Marsh KC, Pauly J, Radek RJ, et al. Preclinical Pharmacology of ABT-418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease Cns Drug Reviews. 1: 1-26. DOI: 10.1111/j.1527-3458.1995.tb00274.x  0.52
1994 Holland LN, Shuster LC, Buccafusco JJ. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat. Neuropharmacology. 32: 1387-95. PMID 8152529 DOI: 10.1016/0028-3908(93)90035-2  0.68
1994 Xiaohong Yang, Buccafusco JJ, Pauly JR. Pharmacological evaluation of methylcarbamylcholine-induced drinking behavior in rats Pharmacology, Biochemistry and Behavior. 49: 1-6. PMID 7816857 DOI: 10.1016/0091-3057(94)90448-0  0.8
1993 Terry AV, Buccafusco JJ, Jackson WJ. Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacology, Biochemistry, and Behavior. 45: 925-9. PMID 8415832 DOI: 10.1016/0091-3057(93)90141-F  1
1993 Terry AV, Jackson WJ, Buccafusco JJ. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys. Cerebral Cortex (New York, N.Y. : 1991). 3: 304-12. PMID 8400808 DOI: 10.1093/cercor/3.4.304  1
1993 Feldman DS, Buccafusco JJ. Localization of cholinergic neurons involved in the cardiovascular response to intrathecal injection of carbachol European Journal of Pharmacology. 250: 483-487. PMID 8112410 DOI: 10.1016/0014-2999(93)90039-K  0.8
1992 Buccafusco JJ, Jackson WJ, Terry AV. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by primates. Life Sciences. 51: PL 7-12. PMID 1614276 DOI: 10.1016/0024-3205(92)90011-D  1
1992 Ray PG, Meador KJ, Loring DW, Zamrini EW, Yang XH, Buccafusco JJ. Central anticholinergic hypersensitivity in aging. Journal of Geriatric Psychiatry and Neurology. 5: 72-7. PMID 1317178 DOI: 10.1177/002383099200500203  0.8
1991 Jackson WJ, Buccafusco JJ. Clonidine enhances delayed matching-to-sample performance by young and aged monkeys. Pharmacology, Biochemistry, and Behavior. 39: 79-84. PMID 1924516 DOI: 10.1016/0091-3057(91)90400-V  0.68
1991 Buccafusco JJ, Jackson WJ. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiology of Aging. 12: 233-8. PMID 1876228 DOI: 10.1016/0197-4580(91)90102-P  0.68
1991 Ray PG, Meador KJ, Loring DW, Murro AM, Buccafusco JJ, Yang XH, Zamrini EY, Thompson WO, Thompson EE. Effects of scopolamine on visual evoked potentials in aging and dementia. Electroencephalography and Clinical Neurophysiology. 80: 347-51. PMID 1716558 DOI: 10.1016/0168-5597(91)90081-8  0.8
1989 Buccafusco JJ, Graham JH, VanLingen J, Aronstam RS. Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicology and Teratology. 11: 39-44. PMID 2725439 DOI: 10.1016/0892-0362(89)90083-4  0.44
1988 Buccafusco JJ, Graham JH, Aronstam RS. Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine. Pharmacology, Biochemistry, and Behavior. 29: 309-13. PMID 3362926 DOI: 10.1016/0091-3057(88)90161-X  0.44
1988 Buccafusco JJ, Aronstam RS, Graham JH. Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor. Toxicology Letters. 42: 291-9. PMID 3176058 DOI: 10.1016/0378-4274(88)90114-2  0.44
1988 Elrod K, Buccafusco JJ, Jackson WJ. Nicotine enhances delayed matching-to-sample performance by primates. Life Sciences. 43: 277-87. PMID 2899825 DOI: 10.1016/0024-3205(88)90318-9  0.68
1985 Kirby ML, Aronstam RS, Buccafusco JJ. Changes in cholinergic parameters associated with failure of conotruncal septation in embryonic chick hearts after neural crest ablation Circulation Research. 56: 392-401. PMID 3971512 DOI: 10.1161/01.RES.56.3.392  0.8
1985 Buccafusco JJ, Serra M. Role of cholinergic neurons in the cardiovascular responses evoked by central injection of bradykinin or angiotensin II in conscious rats European Journal of Pharmacology. 113: 43-51. PMID 2864263 DOI: 10.1016/0014-2999(85)90341-3  0.8
1984 Buccafusco JJ, Marshall DC, Turner RM. A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in rats Life Sciences. 35: 1401-1408. PMID 6148677 DOI: 10.1016/0024-3205(84)90398-9  0.8
Show low-probability matches.